| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |